annual FCF:
-$229.81M-$58.82M(-34.40%)Summary
- As of today (September 10, 2025), CRNX annual free cash flow is -$229.81 million, with the most recent change of -$58.82 million (-34.40%) on December 31, 2024.
- During the last 3 years, CRNX annual FCF has fallen by -$140.79 million (-158.15%).
- CRNX annual FCF is now -3961.75% below its all-time high of -$5.66 million, reached on December 31, 2016.
Performance
CRNX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$89.05M+$638.00K(+0.71%)Summary
- As of today (September 10, 2025), CRNX quarterly free cash flow is -$89.05 million, with the most recent change of +$638.00 thousand (+0.71%) on June 30, 2025.
- Over the past year, CRNX quarterly FCF has dropped by -$40.45 million (-83.24%).
- CRNX quarterly FCF is now -3695.95% below its all-time high of -$2.35 million, reached on March 31, 2017.
Performance
CRNX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$305.77M-$40.45M(-15.25%)Summary
- As of today (September 10, 2025), CRNX TTM free cash flow is -$305.77 million, with the most recent change of -$40.45 million (-15.25%) on June 30, 2025.
- Over the past year, CRNX TTM FCF has dropped by -$118.69 million (-63.45%).
- CRNX TTM FCF is now -12933.72% below its all-time high of -$2.35 million, reached on March 31, 2017.
Performance
CRNX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
CRNX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.4% | -83.2% | -63.5% |
| 3 y3 years | -158.2% | -211.5% | -236.2% |
| 5 y5 years | -390.3% | -461.3% | -453.5% |
CRNX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -158.2% | at low | -211.5% | +0.7% | -236.2% | at low |
| 5 y | 5-year | -390.3% | at low | -553.4% | +0.7% | -453.5% | at low |
| alltime | all time | -3961.8% | at low | -3695.9% | +0.7% | <-9999.0% | at low |
CRNX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$89.05M(-0.7%) | -$305.77M(+15.2%) |
| Mar 2025 | - | -$89.69M(+36.5%) | -$265.32M(+15.4%) |
| Dec 2024 | -$229.81M(+34.4%) | -$65.70M(+7.1%) | -$229.81M(+12.9%) |
| Sep 2024 | - | -$61.32M(+26.2%) | -$203.56M(+8.8%) |
| Jun 2024 | - | -$48.60M(-10.3%) | -$187.08M(+1.4%) |
| Mar 2024 | - | -$54.19M(+37.4%) | -$184.45M(+7.9%) |
| Dec 2023 | -$171.00M(+46.3%) | -$39.45M(-12.0%) | -$171.00M(+2.4%) |
| Sep 2023 | - | -$44.84M(-2.5%) | -$167.03M(+3.5%) |
| Jun 2023 | - | -$45.97M(+12.9%) | -$161.35M(+12.1%) |
| Mar 2023 | - | -$40.73M(+14.8%) | -$143.97M(+23.2%) |
| Dec 2022 | -$116.86M(+31.3%) | -$35.48M(-9.4%) | -$116.86M(+12.0%) |
| Sep 2022 | - | -$39.16M(+37.0%) | -$104.30M(+14.7%) |
| Jun 2022 | - | -$28.59M(+109.8%) | -$90.95M(+10.3%) |
| Mar 2022 | - | -$13.63M(-40.5%) | -$82.47M(-7.4%) |
| Dec 2021 | -$89.02M | -$22.92M(-11.2%) | -$89.02M(+8.5%) |
| Sep 2021 | - | -$25.81M(+28.4%) | -$82.06M(+10.4%) |
| Jun 2021 | - | -$20.11M(-0.4%) | -$74.35M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$20.18M(+26.5%) | -$70.11M(+12.7%) |
| Dec 2020 | -$62.21M(+32.7%) | -$15.96M(-11.9%) | -$62.21M(+4.2%) |
| Sep 2020 | - | -$18.10M(+14.1%) | -$59.73M(+8.1%) |
| Jun 2020 | - | -$15.87M(+29.1%) | -$55.24M(+6.2%) |
| Mar 2020 | - | -$12.29M(-8.8%) | -$52.00M(+10.9%) |
| Dec 2019 | -$46.87M(+128.4%) | -$13.47M(-1.0%) | -$46.87M(+18.1%) |
| Sep 2019 | - | -$13.61M(+7.8%) | -$39.69M(+23.9%) |
| Jun 2019 | - | -$12.62M(+76.1%) | -$32.03M(+32.2%) |
| Mar 2019 | - | -$7.17M(+13.9%) | -$24.22M(+18.0%) |
| Dec 2018 | -$20.52M(+109.7%) | -$6.29M(+5.8%) | -$20.52M(+20.9%) |
| Sep 2018 | - | -$5.94M(+23.3%) | -$16.97M(+25.8%) |
| Jun 2018 | - | -$4.82M(+39.1%) | -$13.49M(+55.6%) |
| Mar 2018 | - | -$3.46M(+26.3%) | -$8.67M(+14.8%) |
| Dec 2017 | -$9.78M(+72.9%) | -$2.74M(+11.4%) | -$7.55M(+57.0%) |
| Sep 2017 | - | -$2.46M(+4.9%) | -$4.81M(+104.9%) |
| Mar 2017 | - | -$2.35M | -$2.35M |
| Dec 2016 | -$5.66M | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual free cash flow?
- What is the all time high annual FCF for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual FCF year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly FCF year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM FCF year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual free cash flow?
The current annual FCF of CRNX is -$229.81M
What is the all time high annual FCF for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual free cash flow is -$5.66M
What is Crinetics Pharmaceuticals, Inc. annual FCF year-on-year change?
Over the past year, CRNX annual free cash flow has changed by -$58.82M (-34.40%)
What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly FCF of CRNX is -$89.05M
What is the all time high quarterly FCF for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly free cash flow is -$2.35M
What is Crinetics Pharmaceuticals, Inc. quarterly FCF year-on-year change?
Over the past year, CRNX quarterly free cash flow has changed by -$40.45M (-83.24%)
What is Crinetics Pharmaceuticals, Inc. TTM free cash flow?
The current TTM FCF of CRNX is -$305.77M
What is the all time high TTM FCF for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM free cash flow is -$2.35M
What is Crinetics Pharmaceuticals, Inc. TTM FCF year-on-year change?
Over the past year, CRNX TTM free cash flow has changed by -$118.69M (-63.45%)